Skip to main content
$176.99 $0.05 (0.0%)

04:00 PM EDT on 06/29/22

Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 4 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Current Price $176.99 Mkt Cap $465.6B
Open $177.22 P/E Ratio 23.48
Prev. Close $176.94 Div. (Yield) $4.52 (2.6%)
Daily Range $176.43 - $178.30 Volume 7,005,670
52-Wk Range $155.72 - $186.69 Avg. Daily Vol. 7,354,751

Caps

How do you think NYSE:JNJ will perform against the market?

Add Stock to CAPS Watchlist

All Players

13,608 Outperform
514 Underperform
 

All-Star Players

2,760 Outperform
61 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:JNJ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (71.53)
Submitted August 06, 2021

Johnson & Johnson is a fairly valued Dividend King that offers the prospect of mid to upper-single-digit annual earnings growth to go along with its market-beating 2.5% yield.

acegdl007 (80.11)
Submitted January 20, 2011

J&J is not a company that has experienced significant growth (in terms of stock price) over the past few years. It has mainly sustained its self on it's brand name recognition that has been significantly tarnished in 2010 due to several recalls.… More

Recent Community Commentary

Read the most recent pitches from players about JNJ.

Recs

0
Member Avatar pagliacci100 (45.69) Submitted: 5/23/2022 1:46:18 PM : Outperform Start Price: $177.60 NYSE:JNJ Score: +2.72

A large-scale Danish study compares mRNA & non-mRNA vaccines as groups. The NONs score higher for variant efficacy AND lower for cardiac side effects w/o the extreme temperature control. IF these results are verified with duplication the JNJ vax is in a great position to be the lead global vax & booster in the future.

Recs

0
Member Avatar aye5788 (38.16) Submitted: 2/28/2022 3:09:47 PM : Outperform Start Price: $160.45 NYSE:JNJ Score: +21.72

123wedgewtrt34t5234t

Recs

1
Member Avatar TMFkodyk123 (71.53) Submitted: 8/6/2021 2:11:18 PM : Outperform Start Price: $168.60 NYSE:JNJ Score: +18.93

Johnson & Johnson is a fairly valued Dividend King that offers the prospect of mid to upper-single-digit annual earnings growth to go along with its market-beating 2.5% yield.

Leaderboard

Find the members with the highest scoring picks in JNJ.

Score Leader

bkrebsy

bkrebsy (97.96) Score: +189.95

All that baby shampoo is making me rich!

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tarfu773 89.07 7/30/2007 Outperform 5Y $38.98 +353.68% +171.24% +182.44 1 Comment
UWxBadger 89.39 7/30/2007 Outperform 5Y $39.00 +353.45% +171.04% +182.41 0 Comment
diediedieno 42.09 7/27/2007 Outperform 5Y $39.01 +353.38% +170.97% +182.41 0 Comment
FoolGutek 71.47 7/27/2007 3/24/2017 Outperform 3Y $38.89 +354.81% +173.04% +181.77 0 Comment
welliou2 78.98 7/30/2007 Outperform 5Y $38.98 +353.75% +171.99% +181.76 0 Comment
Liveitup2626 20.74 7/30/2007 Outperform 5Y $38.98 +353.75% +171.99% +181.76 0 Comment
BosoxNelly24 85.40 7/27/2007 Outperform 3Y $39.06 +352.77% +171.08% +181.69 0 Comment
FPDSGDCO 86.98 7/30/2007 11/11/2008 Outperform 3Y $38.93 +354.29% +172.74% +181.55 0 Comment
bullear1 68.19 7/24/2007 Outperform 3Y $39.94 +342.77% +161.38% +181.39 0 Comment
jbarnes1217 88.06 7/24/2007 Outperform 3Y $39.94 +342.77% +161.38% +181.39 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for JNJ.